4//SEC Filing
Parsons Erin 4
Accession 0001104659-22-011494
CIK 0001372514other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:04 PM ET
Size
8.1 KB
Accession
0001104659-22-011494
Insider Transaction Report
Form 4
Parsons Erin
Director
Transactions
- Award
Stock Option (right to buy)
2022-02-01+4,000→ 4,000 totalExercise: $0.77Exp: 2032-02-01→ Common Stock (4,000 underlying) - Award
Stock Option (right to buy)
2022-02-01+5,000→ 5,000 totalExercise: $0.77Exp: 2032-02-01→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan in connection with the Reporting Person's appointment to the Issuer's Board of Directors. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.
- [F2]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023.
Documents
Issuer
KIORA PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001895795
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:04 PM ET
- Size
- 8.1 KB